Interpharm Holdings Stock Forecast - Simple Exponential Smoothing
| IPAH Stock | USD 0 0.00 0.00% |
The Simple Exponential Smoothing forecasted value of Interpharm Holdings on the next trading day is expected to be 0 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Interpharm Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Interpharm Holdings' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Interpharm Holdings' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Revenue Growth (0.07) |
Using Interpharm Holdings hype-based prediction, you can estimate the value of Interpharm Holdings from the perspective of Interpharm Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Interpharm Holdings on the next trading day is expected to be 0 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Interpharm Holdings after-hype prediction price | USD 0.0041 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Interpharm | Build AI portfolio with Interpharm Stock |
Interpharm Holdings Additional Predictive Modules
Most predictive techniques to examine Interpharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Interpharm using various technical indicators. When you analyze Interpharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Interpharm Holdings Simple Exponential Smoothing Price Forecast For the 24th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Interpharm Holdings on the next trading day is expected to be 0 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Interpharm Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Interpharm Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Interpharm Holdings Stock Forecast Pattern
| Backtest Interpharm Holdings | Interpharm Holdings Price Prediction | Buy or Sell Advice |
Interpharm Holdings Forecasted Value
In the context of forecasting Interpharm Holdings' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Interpharm Holdings' downside and upside margins for the forecasting period are 0 and 0, respectively. We have considered Interpharm Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Interpharm Holdings stock data series using in forecasting. Note that when a statistical model is used to represent Interpharm Holdings stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Interpharm Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Interpharm Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Interpharm Holdings After-Hype Price Prediction Density Analysis
As far as predicting the price of Interpharm Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Interpharm Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Interpharm Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Interpharm Holdings Estimiated After-Hype Price Volatility
In the context of predicting Interpharm Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Interpharm Holdings' historical news coverage. Interpharm Holdings' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Interpharm Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Interpharm Holdings is very steady at this time. Analysis and calculation of next after-hype price of Interpharm Holdings is based on 3 months time horizon.
Interpharm Holdings Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Interpharm Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Interpharm Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Interpharm Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Interpharm Holdings Hype Timeline
Interpharm Holdings is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Interpharm is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Interpharm Holdings is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.09. Interpharm Holdings had not issued any dividends in recent years. The entity had 1:5 split on the 19th of November 1997. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Historical Fundamental Analysis of Interpharm Holdings to cross-verify your projections.Interpharm Holdings Related Hype Analysis
Having access to credible news sources related to Interpharm Holdings' direct competition is more important than ever and may enhance your ability to predict Interpharm Holdings' future price movements. Getting to know how Interpharm Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Interpharm Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PXYN | Praxsyn Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DNAG | DNAPrint Genomics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMMB | Immunotech Laboratories | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| USRM | US Stem Cell | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| JNHMF | Jack Nathan Medical | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 800.00 | |
| SPPH | Spencer Pharmaceutical | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MHTX | Manhattan Scients | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REFG | Medical Cannabis Pay | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INLB | Item 9 Labs | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CBGL | Cannabis Global | 0.00 | 0 per month | 0.00 | 0.11 | 100.00 | (50.00) | 150.00 |
Other Forecasting Options for Interpharm Holdings
For every potential investor in Interpharm, whether a beginner or expert, Interpharm Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Interpharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Interpharm. Basic forecasting techniques help filter out the noise by identifying Interpharm Holdings' price trends.Interpharm Holdings Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Interpharm Holdings stock to make a market-neutral strategy. Peer analysis of Interpharm Holdings could also be used in its relative valuation, which is a method of valuing Interpharm Holdings by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Interpharm Holdings Market Strength Events
Market strength indicators help investors to evaluate how Interpharm Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpharm Holdings shares will generate the highest return on investment. By undertsting and applying Interpharm Holdings stock market strength indicators, traders can identify Interpharm Holdings entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0041 | |||
| Day Typical Price | 0.0041 |
Story Coverage note for Interpharm Holdings
The number of cover stories for Interpharm Holdings depends on current market conditions and Interpharm Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Interpharm Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Interpharm Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of Interpharm Holdings to cross-verify your projections. For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Interpharm Holdings. If investors know Interpharm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Interpharm Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
The market value of Interpharm Holdings is measured differently than its book value, which is the value of Interpharm that is recorded on the company's balance sheet. Investors also form their own opinion of Interpharm Holdings' value that differs from its market value or its book value, called intrinsic value, which is Interpharm Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Interpharm Holdings' market value can be influenced by many factors that don't directly affect Interpharm Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Interpharm Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Interpharm Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Interpharm Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.